Creative Medical Technology Holdings, Inc. (CELZ): Revenue
$6.0K
Year ended 2025-12-31
$3.0K
Trailing 12 months to 2026-06-30
-59.2%
3-year compound annual growth
-48.4%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.0K | -45.5% | 2026-03-20, From 2025-01-01 |
| 2024-12-31 | $11.0K | +22.2% | 2026-03-20, From 2024-01-01 |
| 2023-12-31 | $9.0K | -89.8% | 2025-03-14, From 2023-01-01 |
| 2022-12-31 | $88.6K | +1.0% | 2024-03-22, From 2022-01-01 |
| 2021-12-31 | $87.8K | -46.7% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | $164.5K | -0.6% | 2022-03-30, From 2020-01-01 |
| 2019-12-31 | $165.5K | +33.0% | 2021-03-17, From 2019-01-01 |
| 2018-12-31 | $124.4K | n/m | 2020-04-06, From 2018-01-01 |
| 2017-12-31 | $4.8K | n/a | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | $0 | n/a | 2018-03-29, From 2016-01-01 |
| 2015-12-31 | $0 | n/a | 2016-04-14, From 2015-01-01 |
| 2014-12-31 | $0 | n/a | 2016-04-14, From 2014-01-01 |
| 2013-12-31 | $0 | n/a | 2015-02-27, From 2013-01-01 |
| 2012-12-31 | $0 | n/a | 2014-03-17, From 2012-01-01 |
| 2011-12-31 | $0 | n/a | 2012-03-26, From 2011-01-01 |
| 2010-12-31 | $0 | n/a | 2012-03-26, From 2010-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Creative Medical Technology Holdings, Inc. (CELZ) | 2025-12-31 | $6.0K | -45.5% |
| Senti Biosciences Holdings, Inc. (SNTI) | 2025-12-31 | $22.0K | n/a |
| Entera Bio Ltd. (ENTX) | 2025-12-31 | $42.0K | -76.8% |
| Inmune Bio, Inc. (INMB) | 2025-12-31 | $50.0K | +257.1% |
| AIM ImmunoTech Inc. (AIM) | 2025-12-31 | $88.0K | -48.2% |
| VivoSim Labs, Inc. (VIVS) | 2026-03-31 | $131.0K | -9.0% |
| Zivo Bioscience, Inc. (ZIVO) | 2024-12-31 | $157.2K | +468.6% |
| aTYR PHARMA INC (ATYR) | 2025-12-31 | $190.0K | -19.1% |
| Cardiff Oncology, Inc. (CRDF) | 2025-12-31 | $593.0K | -13.2% |
Compare CELZ, SNTI, ENTX, INMB side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗